Ads
related to: gene journal impact factor 2024 list of medications for diabetes- See the FAQs
Get the Answers to Frequently
Asked Questions Today.
- View Patient Stories
Watch Videos of Patient Stories
Today to Start Your T1D Journey.
- Join the Support Program
View Resources & Copay Assistance.
Terms & Conditions Apply.
- Talk to Your Doctor
Download the Discussion Guide
to Start the Conversation Today.
- See the FAQs
Search results
Results From The WOW.Com Content Network
It is published by Elsevier and the editor-in-chief is Marianna Kruithof-de Julio (University of Bern) The Gene Family of journals comprises the journals Gene, Gene Reports, Human Gene, and Plant Gene. According to the Journal Citation Reports, the journal has a 2022 impact factor of 3.5. [1]
The Journal of Gene Medicine is a monthly peer-reviewed medical journal covering gene therapy and other uses of genetic technologies for medical purposes. It was established in 1999 and is published by John Wiley & Sons. The editors-in-chief is Gening Jiang (Tongji University).
The Journal of Diabetes is a monthly peer-reviewed medical journal that covers research, therapeutics, and education in the field of diabetes mellitus. It is published by Wiley and is an official journal of the Chinese Society of Endocrinology and endorsed by the Chinese Endocrinologist Association .
Diabetes: American Diabetes Association: English: 1952–present Diabetes and Vascular Disease Research: Diabetes: SAGE Publishing: English: 2004–present Diabetes Care: Diabetes: American Diabetes Association: English: 1978–present Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy: Diabetes: Dove Medical Press: English: 2008 ...
Genes is a quarterly peer-reviewed open access scientific journal that is published by MDPI. The editor-in-chief is J. Peter W. Young (University of York). [1] It covers all topics related to genes, genetics, and genomics.
Cambiogenplasmid (Neovasculgen): treatment for vascular endothelial growth factor peripheral artery disease Ciltacabtagene autoleucel (Carvykti): treatment for multiple myeloma [ 6 ] Delandistrogene moxeparvovec (Elevidys): treatment for Duchenne muscular dystrophy [ 7 ] [ 8 ]
The journal was established in 1988 in response to the rapid increase in research output in the areas of molecular and genetic endocrinology that had occurred as a result of technological advancements of the 1970s and 1980s, such as the development of recombinant DNA techniques, DNA sequencing, and the invention of the polymerase chain reaction ...
Diabetes also publishes abstracts presented at the ADA's annual meeting, Scientific Sessions, as a supplement. According to the Journal Citation Reports , the journal has a 2021 impact factor of 9.337, and a 5 years impact factor of 10.509 ranking it 8th out of 240 journals in the category "Endocrinology, Diabetes & Metabolism".